[Structural variation in the human genome contributes to variation of traits].

PubWeight™: 0.79‹?›

🔗 View Article (PMID 18787571)

Published in Tidsskr Nor Laegeforen on September 11, 2008

Authors

Tuva Barøy1, Doriana Misceo, Eirik Frengen

Author Affiliations

1: Avdeling for medisinsk genetikk, Ullevål universitetssykehus, Oslo.

Articles by these authors

Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell (2012) 2.61

A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response. PLoS One (2009) 2.29

Human-specific duplication and mosaic transcripts: the recent paralogous structure of chromosome 22. Am J Hum Genet (2001) 1.95

A preliminary comparative analysis of primate segmental duplications shows elevated substitution rates and a great-ape expansion of intrachromosomal duplications. Genome Res (2006) 1.69

Refinement of a chimpanzee pericentric inversion breakpoint to a segmental duplication cluster. Genome Biol (2003) 1.65

Recurrent sites for new centromere seeding. Genome Res (2004) 1.54

A highly redundant BAC library of Atlantic salmon (Salmo salar): an important tool for salmon projects. BMC Genomics (2005) 1.37

Evolutionary movement of centromeres in horse, donkey, and zebra. Genomics (2006) 1.34

Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene (2002) 1.31

Human paralogs of KIAA0187 were created through independent pericentromeric-directed and chromosome-specific duplication mechanisms. Genome Res (2002) 1.10

Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy. Neurology (2016) 1.02

Refinement of macaque synteny arrangement with respect to the official rheMac2 macaque sequence assembly. Chromosome Res (2008) 1.01

siRNA: a potential tool for future breast cancer therapy? Crit Rev Oncog (2006) 0.94

A dominant STIM1 mutation causes Stormorken syndrome. Hum Mutat (2014) 0.90

Increasing the resolution of the comet assay using fluorescent in situ hybridization--a review. Mutagenesis (2009) 0.89

Evolutionary history of chromosome 11 featuring four distinct centromere repositioning events in Catarrhini. Genomics (2007) 0.88

Kaufman oculocerebrofacial syndrome in sisters with novel compound heterozygous mutation in UBE3B. Am J Med Genet A (2015) 0.86

A map of nuclear matrix attachment regions within the breast cancer loss-of-heterozygosity region on human chromosome 16q22.1. Genomics (2006) 0.84

A mild form of Mucopolysaccharidosis IIIB diagnosed with targeted next-generation sequencing of linked genomic regions. Eur J Hum Genet (2011) 0.83

A satellite-like sequence, representing a "clone gap" in the human genome, was likely involved in the seeding of a novel centromere in macaque. Chromosoma (2008) 0.82

X-linked congenital adrenal hypoplasia with hypogonadotropic hypogonadism caused by an inversion disrupting a conserved noncoding element upstream of the NR0B1 (DAX1) gene. J Clin Endocrinol Metab (2009) 0.81

Haploinsufficiency of two histone modifier genes on 6p22.3, ATXN1 and JARID2, is associated with intellectual disability. Orphanet J Rare Dis (2013) 0.80

Inheritance of a terminal 7.1 Mb 18p deletion flanked by a 2.3 Mb duplication from a physically normal mother. Am J Med Genet A (2009) 0.80

A retroviral vector for siRNA expression in mammalian cells. Mol Biotechnol (2007) 0.78

A de novo 15q13.2q13.3 deletion in a boy with an Angelman syndrome like phenotype. Eur J Med Genet (2010) 0.77

A de novo 6p interstitial deletion and a complex translocation involving chromosomes 2, 6, and 14 in a mildly developmentally delayed patient. Am J Med Genet A (2008) 0.76

A 1 Mb de novo deletion within 11q13.1q13.2 in a boy with mild intellectual disability and minor dysmorphic features. Eur J Med Genet (2012) 0.76

Regulated expression of a transgene introduced on an oriP/EBNA-1 PAC shuttle vector into human cells. BMC Biotechnol (2009) 0.75

shRNA expression constructs designed directly from siRNA oligonucleotide sequences. Mol Biotechnol (2010) 0.75

A partial trisomy 1q patient with a deletion 1q22 and an insertion 1(q42q44) into 1q22. Am J Med Genet A (2009) 0.75

Hyperphagia, mild developmental delay but apparently no structural brain anomalies in a boy without SOX3 expression. Am J Med Genet A (2013) 0.75

A balanced de novo inv(7)(p14.3q22.3) disrupting PDE1C and ATXN7L1 in a 14-year old developmentally delayed boy. Eur J Med Genet (2013) 0.75